Meridian Wealth Partners’s Repligen RGEN Stock Holding History

Meridian Wealth Partners’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-78	Closed	-$16K	–	995
2021 Q1	$16K	Buy	+78	New	+$16K	﹤0.01%	337

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Meridian Wealth Partners's RGEN Position: Q2 2021 in Review

Meridian Wealth Partners sold out of Repligen (RGEN) in Q2 2021, closing a stake of 78 shares — an estimated $16K sold.

Meridian Wealth Partners first reported a position in RGEN in Q1 2021 and held it in 1 quarter. The position peaked at $16K in Q1 2021. 428 funds tracked by Wall St. Rank hold RGEN as of Q2 2021.

Meridian Wealth Partners reported no remaining Repligen position as of Q2 2021 after selling out during the quarter.
Meridian Wealth Partners sold 78 Repligen shares in Q2 2021, an estimated $16K.
Meridian Wealth Partners first reported a position in Repligen in Q1 2021 and held it in 1 quarter.
Meridian Wealth Partners's Repligen position peaked at $16K in Q1 2021.
428 funds tracked by Wall St. Rank held Repligen as of Q2 2021.

Based on Meridian Wealth Partners's 13F filing for Q2 2021, filed 12 Aug 2021.